Swiss National Bank Acquires 4,300 Shares of NextGen Healthcare, Inc. (NASDAQ:NXGN)

Swiss National Bank lifted its holdings in NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) by 3.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 139,600 shares of the company’s stock after acquiring an additional 4,300 shares during the quarter. Swiss National Bank’s holdings in NextGen Healthcare were worth $2,622,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. Dimensional Fund Advisors LP lifted its holdings in shares of NextGen Healthcare by 0.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,346,449 shares of the company’s stock worth $49,065,000 after acquiring an additional 18,533 shares during the last quarter. State Street Corp raised its holdings in NextGen Healthcare by 1.0% during the 2nd quarter. State Street Corp now owns 2,057,577 shares of the company’s stock valued at $35,884,000 after buying an additional 20,037 shares during the last quarter. Lazard Asset Management LLC raised its holdings in NextGen Healthcare by 10,233.1% during the 3rd quarter. Lazard Asset Management LLC now owns 1,065,959 shares of the company’s stock valued at $18,867,000 after buying an additional 1,055,643 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in NextGen Healthcare by 108.5% during the 4th quarter. Assenagon Asset Management S.A. now owns 865,662 shares of the company’s stock valued at $16,257,000 after buying an additional 450,521 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in NextGen Healthcare by 8.5% during the 2nd quarter. Northern Trust Corp now owns 761,067 shares of the company’s stock valued at $13,273,000 after buying an additional 59,799 shares during the last quarter. 73.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on NXGN shares. TheStreet lowered shares of NextGen Healthcare from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. Piper Sandler lowered their price target on shares of NextGen Healthcare from $20.00 to $17.00 in a report on Thursday, May 18th. Truist Financial lowered their price target on shares of NextGen Healthcare from $22.00 to $18.00 in a report on Monday. StockNews.com initiated coverage on shares of NextGen Healthcare in a research report on Thursday, May 18th. They set a “buy” rating on the stock. Finally, Guggenheim reduced their price objective on shares of NextGen Healthcare from $26.00 to $22.00 in a research report on Tuesday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, NextGen Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $21.20.

NextGen Healthcare Stock Up 0.1 %

NASDAQ:NXGN opened at $15.66 on Wednesday. The firm’s 50-day moving average price is $17.04 and its 200-day moving average price is $18.18. The company has a market capitalization of $1.03 billion, a PE ratio of -391.50 and a beta of 1.04. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.03 and a quick ratio of 2.53. NextGen Healthcare, Inc. has a 1-year low of $15.23 and a 1-year high of $21.99.

About NextGen Healthcare

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.